Search - tctmd.com

Displaying 21 - 35 of 35

Sort: Relevancy | Date

News Opinion CV Team Dispatch

March 2025 Dispatch for the CV Team

L.A. McKeown

March 21, 2025

News Daily News

Some Mitral TEER Patients Slipping Through the Cracks in the First Month

Michael O'Riordan

March 21, 2025

News Daily News

Vutrisiran, With the FDA’s Sign-off, Joins the Fray for ATTR-CM

Caitlin E. Cox

March 21, 2025

News Daily News

REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF

Michael O'Riordan

March 11, 2025

News Daily News

Finerenone Cuts Intensification of Oral Diuretics in Outpatient Setting: FINEARTS-HF

Michael O'Riordan

March 03, 2025

News Daily News

Sotagliflozin Reduces Ischemic Risk in SCORED Analysis

Yael L. Maxwell

February 25, 2025

News Daily News

Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time

Michael O'Riordan

February 13, 2025

News Conference News THT 2025

AIM-POWER: Remote, App-Based Intervention Boosts GDMT Use in HFrEF

Todd Neale

February 13, 2025

News Conference News THT 2025

Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity

Todd Neale

February 12, 2025

News Daily News

Acoramidis Approved in Europe for ATTR Cardiomyopathy

Michael O'Riordan

February 12, 2025

News Opinion CV Team Dispatch

February 2025 Dispatch for the CV Team

L.A. McKeown

February 01, 2025

News Opinion CV Team Dispatch

January 2025 Dispatch for the CV Team

L.A. McKeown

January 24, 2025

News Daily News

Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3

Yael L. Maxwell

January 15, 2025

News Daily News

Change in Kidney Function With Finerenone Doesn’t Impact Treatment’s Benefit

Michael O'Riordan

January 13, 2025

Presentation AHA 2024

Routine spironolactone in Acute Myocardial Infarction, results from the CLEAR SYNERGY OASIS 9 trial

Presenter: Sanjit S Jolly

November 17, 2024

Advertisement

March 2025 Dispatch for the CV Team

Some Mitral TEER Patients Slipping Through the Cracks in the First Month

Vutrisiran, With the FDA’s Sign-off, Joins the Fray for ATTR-CM

REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF

Finerenone Cuts Intensification of Oral Diuretics in Outpatient Setting: FINEARTS-HF

Sotagliflozin Reduces Ischemic Risk in SCORED Analysis

Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time

AIM-POWER: Remote, App-Based Intervention Boosts GDMT Use in HFrEF

Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity

Acoramidis Approved in Europe for ATTR Cardiomyopathy

February 2025 Dispatch for the CV Team

January 2025 Dispatch for the CV Team

Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3

Change in Kidney Function With Finerenone Doesn’t Impact Treatment’s Benefit

Routine spironolactone in Acute Myocardial Infarction, results from the CLEAR SYNERGY OASIS 9 trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content